Intercept Pharmaceuticals, Inc. EBITDA 2013-2023 | ICPT
Intercept Pharmaceuticals, Inc. ebitda from 2013 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Intercept Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-66 |
| 2021 | $-60 |
| 2020 | $-194 |
| 2019 | $-286 |
| 2018 | $-265 |
| 2017 | $-313 |
| 2016 | $-387 |
| 2015 | $-221 |
| 2014 | $-109 |
| 2013 | $-38 |
| 2012 | $-19 |
| 2011 | $-13 |
| 2010 | $-16 |
| Intercept Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-6 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-33 |
| 2022-12-31 | $-19 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-12 |
| 2022-03-31 | $-24 |
| 2021-12-31 | $-27 |
| 2021-09-30 | $-9 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-20 |
| 2020-12-31 | $-30 |
| 2020-09-30 | $-46 |
| 2020-06-30 | $-43 |
| 2020-03-31 | $-75 |
| 2019-12-31 | $-81 |
| 2019-09-30 | $-68 |
| 2019-06-30 | $-57 |
| 2019-03-31 | $-79 |
| 2018-12-31 | $-77 |
| 2018-09-30 | $-53 |
| 2018-06-30 | $-65 |
| 2018-03-31 | $-70 |
| 2017-12-31 | $-99 |
| 2017-09-30 | $-60 |
| 2017-06-30 | $-75 |
| 2017-03-31 | $-79 |
| 2016-12-31 | $-108 |
| 2016-09-30 | $-78 |
| 2016-06-30 | $-76 |
| 2016-03-31 | $-125 |
| 2015-12-31 | $-86 |
| 2015-09-30 | $-49 |
| 2015-06-30 | $-47 |
| 2015-03-31 | $-39 |
| 2014-12-31 | $-34 |
| 2014-09-30 | $-35 |
| 2014-06-30 | $-22 |
| 2014-03-31 | $-19 |
| 2013-12-31 | $-13 |
| 2013-09-30 | $-11 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-3 |
